RLN2 and atrial fibrillation: Several preclinical models have demonstrated that relaxin-2 reduces AF susceptibility after MI [111], and in aged hypertensive rats [112,113], being one of the possible mechanisms of the regulation of ionic currents and inotropy in cardiac cells [112,114].